CasaburiR. Long-term oxygen therapy: the three big questions. Ann Am Thorac Soc, 2018; 15(1):14–15.
4.
AlMutairiH, MussaCC, LambertCTM, VinesDL, StricklandS. Perspectives from COPD subjects on portable LTOT devices. Respir Care, 2018; 63(11):1321–1330.
5.
JacobsSS, LindellKO, CollinsEG, GarveyCM, HernandezC, McLaughlinS, et al. Patient perceptions of the adequacy of supplemental oxygen therapy: results of the American Thoracic Society Nursing Assembly Oxygen Working Group Survey. Ann Am Thorac Soc, 2018; 15(1):24–32.
6.
ArnoldE, BrutonA, Donovan-HallM, FenwickA, DibbB, WalkerE. Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm Med, 2011; 11–19.
7.
HartmanJE, BoezenHM, de GreefMH, Ten HackenNH. Physical and psychosocial factors associated with physical activity in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil, 2013; 94(12):2396–2402.e7.
8.
LindellK, OCL, CollinsEG, GarveyCM, HernandezC, McLaughlinS, SchneidmanAM, MeekPM, JacobsSS. Equipment, access and worry about running short of oxygen: key concerns in the patient supplemental oxygen survey. Am J Respir Crit Care Med, 2017; 195(A7646).
9.
Garcia-AymerichJ, LangeP, BenetM, SchnohrP, AntóJM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax, 2006; 61(9):772–778.
10.
LacasseY, LecoursR, PelletierC, BéginR, MaltaisF. Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J, 2005; 25(6):1032–1038.
11.
CasaburiR, PorszaszJ, HechtA, TiepB, AlbertRK, AnthonisenNR, et al. COPD Clinical Research Network. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD, 2012; 9(1):3–11.
12.
PépinJL, BarjhouxCE, DeschauxC, BrambillaC. Long-term oxygen therapy at home: compliance with medical prescription and effective use of therapy. Chest, 1996; 109(5):1144–1150.
13.
ViscaD, MoriL, TsipouriV, FlemingS, FirouziA, BoniniM, et al. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. Lancet Respir Med, 2018; 6(10):759–770.
